E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 938.2 ILS 3.33% Market Closed
Market Cap: 276.9m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note
EPIT
/
Income Statement
/
Revenue

Epitomee Medical Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epitomee Medical Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
E
Epitomee Medical Ltd
TASE:EPIT
Revenue
$10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Revenue
$9.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Revenue
$31.8m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
39%
Inmode Ltd
NASDAQ:INMD
Revenue
$423.7m
CAGR 3-Years
10%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Revenue
$356.4m
CAGR 3-Years
18%
CAGR 5-Years
17%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Revenue
$50.3m
CAGR 3-Years
127%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Epitomee Medical Ltd
Glance View

Market Cap
276.9m ILS
Industry
Health Care

Epitomee Medical Ltd. develops and manufactures medical devices for obesity. The firm operates directly in the field of development, production and commercialization of medical platforms that are divided into two areas: the area of medical devices for weight loss and overweight, including the development and production of medical devices packed in capsules and ingested; the area of solutions for the introduction of drugs through ingestion that allows patients to take various medications that can be administered today only by injections. Both of the Company's solutions are intended for ingestion for patients for self-use, under a doctor's prescription and are under development.

EPIT Intrinsic Value
267.25 ILS
Overvaluation 72%
Intrinsic Value
Price
E
What is Intrinsic Value?

See Also

What is Epitomee Medical Ltd's Revenue?
Revenue
10m USD

Based on the financial report for Dec 31, 2023, Epitomee Medical Ltd's Revenue amounts to 10m USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.